Interchange Capital Partners, LLC Actinium Pharmaceuticals, Inc. Transaction History
Interchange Capital Partners, LLC
- $279 Million
- Q3 2024
A detailed history of Interchange Capital Partners, LLC transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Interchange Capital Partners, LLC holds 19,646 shares of ATNM stock, worth $27,504. This represents 0.01% of its overall portfolio holdings.
Number of Shares
19,646Holding current value
$27,504% of portfolio
0.01%Shares
6 transactions
Others Institutions Holding ATNM
# of Institutions
75Shares Held
8.32MCall Options Held
65.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY1.88MShares$2.63 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.63MShares$2.28 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA686KShares$960,6140.0% of portfolio
-
State Street Corp Boston, MA603KShares$843,7080.0% of portfolio
-
Acadian Asset Management LLC Boston, MA454KShares$635,1710.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $35.3M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...